OREANDA-NEWS. October 23, 2015. Celanese Corporation (NYSE: CE), a global technology and specialty materials company, will present its EVA pharmaceutical material solutions at the 2015 AAPS Annual Meeting and Exposition in Orlando, Fla. Celanese will exhibit its pharmaceutical controlled release copolymer, VitalDose® EVA, October 25-29, 2015 at booth 316.

Celanese material experts will discuss the latest developments in pharmaceutical material science and how ethylene vinyl acetate (EVA) is being used in new drug delivery innovations. VitalDose® EVA controlled release excipients deliver reliable performance with customizable release properties that are compatible with many active pharmaceutical ingredients.

“The unique properties of EVA controlled release excipients allow for customizable delivery rates that are expanding pharmaceutical possibilities,” said Kelsey Achenbach, Celanese strategic marketing manager. “VitalDose EVA offers flexible delivery systems and process versatility backed by high-touch technical expertise to assist from project conception through design and regulatory approval.”

Celanese Presentation Sessions:

  • Kelsey Achenbach, strategic marketing manager, will present “Driving Pharmaceutical Innovation with EVA” on Monday, October 26, 2015 at 2:05 p.m.
  • Jose Reyes, strategic marketing manager, will present “EVA Foamed Excipient: Novel Way to Deliver Stem Cells, Growth Factors, and Biologics for Controlled Release Applications” in a poster presentation on Tuesday, October 27, 2015 at 8:30 a.m.

For more information about Celanese’s controlled release pharmaceutical EVA polymer, VitalDose® EVA, please visit www.vitaldose.com.